The global ophthalmic devices market size is projected to grow from USD 68,300.6 Mn in 2026 to USD 91,927.4 Mn by 2033, registering a compound annual growth rate (CAGR) of 4.3% during the forecast period (2026-2033). This growth is mainly driven by the rising prevalence of ophthalmic disorders such as cataracts, glaucoma, and refractive errors, increasing geriatric population, growing demand for advanced diagnostic and surgical ophthalmic devices, and continuous technological advancements in eye care equipment and vision correction solutions. Globally, at least 2.2 billion people live with vision impairment, of whom at least 1 billion have preventable or untreated conditions.
Vision care devices are forecasted to lead the global ophthalmic devices market in 2026, holding about 45% of the market revenue. The growth drivers of this segment include the rise in cases of refractive errors, growing use of glasses and contact lenses, and increased awareness related to vision correction.
Growing exposure to screens, increasing cases of myopia in both children and adults, and increased availability of low-cost vision correction wear are further fueling demand for vision care devices. Further, innovations in light-weight lenses, blue light filters, and smart lenses are driving segment growth.
In October 2025, Johnson & Johnson announced new clinical data for its ACUVUE OASYS MAX 1-Day contact lenses highlighting enhanced comfort, moisture retention, and improved visual performance during computer and digital device usage.

To learn more about this report, Request Free Sample
Hospitals are projected to be the leading segment, accounting for close to 49% of the market share, in the global ophthalmic devices market in 2026 owing to the advanced ophthalmic surgical facilities, availability of skilled ophthalmologists, and capacity to handle large volumes of patients. Hospitals are well-equipped with advanced ophthalmic diagnostic and surgical systems for cataract, retinal, glaucoma, and corneal procedures.
In February 2025, Carl Zeiss Meditec AG expanded its ophthalmic surgical visualization and microscopy solutions for hospitals and specialty eye centers to support growing ophthalmic surgical demand globally.
The growing impact of visual impairments and ocular diseases is one of the major factors that are positively impacting the market for ophthalmic devices. An increase in the occurrence of cataract, glaucoma, diabetic retinopathy, and refractive disorders is creating the need for modern medical and surgical ophthalmic devices. Other reasons contributing to the rising incidence rate of ocular ailments include exposure to screens, lifestyle changes, and diabetes prevalence.
According to the World Health Organization (WHO), more than 2.2 billion people globally live with near or distance vision impairment, while at least 1 billion cases could have been prevented or remain untreated.
Rapid growth in the global geriatric population is further accelerating demand for ophthalmic diagnostic and surgical devices. Senior patients are exposed to several kinds of eye diseases related to old age, including cataracts, AMD, glaucoma, and presbyopia. This is increasing demand for advanced ophthalmic diagnostic and surgical technologies.
According to the United Nations World Population Ageing Report, the number of persons aged 65 years and older worldwide will increase over 100 percent by the year 2050.
|
Current Event |
Description and its Impact |
|
Expansion of AI-Powered Ophthalmic Diagnostics and Surgical Platforms |
|
|
Rising Global Cataract Surgery Volumes and Aging Population |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Request Free Sample
North America leads due to the availability of highly developed healthcare infrastructure, high adoption rate of technologically advanced eye care devices, and growing instances of vision disorders. The regional market is projected to represent about 41% of market shares in 2026 due to the growing need for retinal imaging devices, OCT instruments, cataract surgery devices, and AI-based ophthalmology diagnostics.
In March 2025, Topcon Healthcare introduced an AI-powered OCT and retinal imaging platform integrating automated disease detection and cloud-based ophthalmic data management.
Asia-Pacific is expected to register the fastest CAGR during 2026-2033 owing to the increasing aging population, rising cases of diabetes, growing number of cataract cases, and investments in the healthcare infrastructure in emerging countries like China and India. Moreover, rising awareness about early detection of eye disorders is anticipated to boost the regional market growth.
According to the World Health Organization, at least 2.2 billion people globally have near or distance vision impairment, and in at least 1 billion of these cases, vision impairment could have been prevented or has yet to be addressed.
The United States ophthalmic devices market is experiencing significant growth due to the aging population, rise in cataracts, diabetic retinopathy, glaucoma, and the adoption of modern eye devices technology. As per statistics from the CDC, over 3.4 million Americans above 40 years of age are either legally blind or have visual impairment, whereas 20.5 million Americans above 40 years suffer from cataracts. In addition to this, millions of cataract surgeries are being conducted in the nation each year.
The Japan ophthalmic devices market is expected to witness significant growth during the forecast period, driven by the fast-aging population in Japan along with an increasing prevalence of age-related eye diseases. Based on data provided by the World Bank and the government of Japan, about 30% of Japan's population consists of people over 65 years of age, indicating that Japan is one of the most aged societies in the world.
Some of the major key players in Ophthalmic Devices are Carl Zeiss Meditec Group, Escalon Medical Corp., Haag-Streit AG, Heidelberg Engineering GmbH, Heine Optotechnik GmbH & Co. KG, Essilor International S.A., NIDEK CO., LTD., Quantel Medical SAS, Luneau Technology Group, and Topcon Corporation.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 68,300.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.3% | 2033 Value Projection: | USD 91,927.4 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Carl Zeiss Meditec Group, Escalon Medical Corp., Haag-Streit AG, Heidelberg Engineering GmbH, Heine Optotechnik GmbH & Co. KG, Essilor International S.A., NIDEK CO., LTD., Quantel Medical SAS, Luneau Technology Group, and Topcon Corporation. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients